SEC Form D private-offering filing

OS Therapies Inc

Name: OS Therapies Inc - new SEC Form D private-offering filing, Grasonville, MD
Published: 2026-01-20

A new SEC Form D private-offering notice from Grasonville, MD, a $7,531,884 filer-stated offering target in Biotech. The source filing is one click away.

OS Therapies Inc site↗ Verified via SEC Form D

Clinical stage cancer immunotherapy company developing OST HER2 and an antibody drug conjugate platform to treat osteosarcoma and other HER2 expressing solid tumors

Filed 2026-01-20Filed to raise $7,531,884First money in 2026-01-14Raised so far $3,498,650HQ (as filed) Grasonville, MDSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified ostherapies.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.